ARCHIVES

Capitol Hill: Senate bill would allow sale of therapies for catastrophic illness after phase I trials.

This article is from The Cancer Letter archive.

Vol. 31 No. 44 | December 2, 2005

Download PDF Visit The Full Archive

Related Articles

Lymphoseek Label Updated To Include Head and Neck SCC

June 27, 2014

ACS Says 41 Percent Survive 5 Years

January 2, 1981

European Treatment Regimen Less Toxic Than American Method

April 26, 2013

In Brief: Preyer, Waxman Battle Over Chairmanship Of Health Group; Amos To Head Mas. ACS

January 12, 1979

House Panel Recommends $642 Million Increase For NIH; $31 Million Increase For NCI

July 21, 1995

Shaky Start For FY11 Appropriations Cycle As Congress Feels Pressure to Cut Spending

June 4, 2010